(Q44438553)

3 December 2017

Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501 (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

1 January 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

1 January 2024

11

Southwest Oncology Group

1 reference

3 December 2017

Danika Lew

2

1 reference

3 December 2017

William S. Velasquez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Thomas M. Grogan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

C. Harris Spiridonidis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Stanley P. Balcerzak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Shaker R. Dakhil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Thomas P. Miller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Keith S. Lanier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Robert A. Chapman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Richard I. Fisher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

Southwest Oncology Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743154

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743154

full work available at URL

1 January 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.09.047

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Journal of Clinical Oncology

1 January 2024

published in

1 reference

3 December 2017

21

1 reference

3 December 2017

1996-2003

1 reference

3 December 2017

10

1 reference

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

3 December 2017

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities?

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimen

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Infections in patients with chronic lymphocytic leukemia treated with fludarabine

1 January 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Nonparametric Estimation from Incomplete Observations

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group

1 January 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

1 January 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 January 2024

29

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.047

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference